首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1461289

全球醫藥中間體市場，依中間體類型、依應用、依最終用戶、依地理位置

Global Pharmaceutical Intermediates Market, By Intermediate Type, By Application, By End User, By Geography

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年醫藥中間體市場價值為436.7億美元，預計到2031年將達到751.2億美元，2024年至2031年年複合成長率(CAGR)為8.1%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	436.7 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	8.10%	2030/2031 價值預測：	751.2 億美元

全球醫藥中間體市佔率 (%)，依地區，2024 年

過去幾年，醫藥中間體市場取得了顯著成長。醫藥中間體是在藥物合成的各個步驟中產生的化合物。它們有助於以最少的資源有效地大量生產藥物。慢性病盛行率的上升以及製藥公司研發投資的增加刺激了對中間體的需求。此外，全球易患慢性病的老年人口不斷成長，對市場成長產生了積極影響。然而，新中間體核准的嚴格監管框架以及建立生產設施的高資本要求是限制市場成長的一些課題。總體而言，中間體在簡化藥物生產過程中的廣泛使用預示著未來幾年市場擴張的巨大機會。

市場動態：

全球醫藥中間體市場主要是由生活方式引起的慢性疾病（如糖尿病、癌症、心血管疾病等）發病率不斷上升所推動的。另一方面，與開發新型中間體相關的高研發成本以及監管機構核准時間長等因素正在減緩市場進展。此外，老牌企業之間的激烈競爭也為新進者帶來了重大課題。然而，發展中國家日益成長的醫藥外包趨勢為市場參與者提供了利潤豐厚的機會。開發安全、環保中間體的持續技術創新將進一步支持預測期內的市場擴張。

研究的主要特點：

該報告對全球醫藥中間體市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）對全球醫藥中間體市場的主要參與者進行了介紹。
本研究涵蓋的主要公司包括贏創、Borregaard AS、Sudarshan Pharma、AR Life Science、Actylis、Saurav Chemicals Ltd.、Lianhetech、Midas Pharma GmbH、Sanofi、BASF SE、Chiracon GmbH、Lonza、Chemcon Specialty Chemicals Limited ., Modepro SE印度列兵。有限公司、Lifechem Pharma、Sarex 和朗盛。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球醫藥中間體市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球醫藥中間體市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 8 章：公司概況 - 全球醫藥中間體市場

Evonik
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
Borregaard AS
Sudarshan Pharma
AR Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS

第 9 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6740

The pharmaceutical intermediates market is estimated to be valued at USD 43.67 Bn in 2024 and is expected to reach USD 75.12 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 43.67 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.10%	2030/2031 Value Projection:	US$ 75.12 Bn

Global Pharmaceutical Intermediates Market Share (%), By Region, 2024

Global Pharmaceutical Intermediates Market - IMG1

The pharmaceutical intermediates market has been witnessing significant growth over the past few years. Pharmaceutical intermediates are chemical compounds produced during the various steps of pharmaceutical drug synthesis. They help in efficiently manufacturing drugs in large quantities with minimum resources. Rising prevalence of chronic diseases along with increasing R&D investments by pharmaceutical companies are fueling the demand for intermediates. Additionally, the growing geriatric population worldwide prone to chronic medical conditions is positively influencing the market growth. However, strict regulatory frameworks for the approval of new intermediates and high capital requirement for setting up manufacturing facilities are some challenges restraining the market growth. Overall, the widespread use of intermediates in streamlining drug production processes indicates huge opportunities for market expansion in the coming years.

Market Dynamics:

The global pharmaceutical intermediates market is primarily driven by the growing incidence of lifestyle-induced chronic diseases like diabetes, cancer, cardiovascular disorders, etc. Favorable government policies supporting local drug manufacturing is another key factor pushing the market growth. On the other hand, factors like high R&D costs associated with developing novel intermediates and lengthy approval times from regulatory bodies are slowing the market progress. Also, intense competition among established players poses major challenge to new entrants. However, rising pharmaceutical outsourcing trends from developing countries present lucrative opportunities for market players. Continued technological innovations to develop safe and eco-friendly intermediates will further support the market expansion over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical intermediates market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical intermediates market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Evonik, Borregaard AS, Sudarshan Pharma, A.R. Life Science, Actylis, Saurav Chemicals Ltd., Lianhetech, Midas Pharma GmbH, Sanofi , BASF SE, Chiracon GmbH, Lonza, Chemcon Speciality Chemicals Limited., Modepro India Pvt. Ltd., Lifechem Pharma, Sarex, and LANXESS.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global pharmaceutical intermediates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical intermediates market.

Detailed Segmentation:

Intermediate Type:
- Bulk Intermediate
- Chemical Intermediate
Application:
- Anti-Infective Drugs
- Analgesics
- Antidiabetic Drugs
- Cardiovascular Drugs
- Antimicrobial Drugs
- Anti-inflammatory Drugs
- Others
End User:
- Biopharmaceutical Companies
- CMO
- CRO
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Evonik
- Borregaard AS
- Sudarshan Pharma
- R. Life Science
- Actylis
- Saurav Chemicals Ltd.
- Lianhetech
- Midas Pharma GmbH
- Sanofi
- BASF SE
- Chiracon GmbH
- Lonza
- Chemcon Speciality Chemicals Limited.
- Modepro India Pvt. Ltd.
- Lifechem Pharma
- Sarex
- LANXESS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Intermediate Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending, by Country
Manufacturing Capacities
Distributors Landscape

4. Global Pharmaceutical Intermediates Market, By Intermediate Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Bulk Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chemical Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Pharmaceutical Intermediates Market, By Application, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Anti-Infective Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antidiabetic Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cardiovascular Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antimicrobial Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Anti-inflammatory Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Pharmaceutical Intermediates Market, By End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CMO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CRO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Pharmaceutical Intermediates Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Company Profiles - Global Pharmaceutical Intermediates Market

Evonik
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Borregaard AS
Sudarshan Pharma
A.R. Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS